Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI Canada (TSX) (EWC) vs UnitedHealth Group Inc (UNH) Price & Performance

iShares MSCI Canada (TSX)Trade
UnitedHealth Group IncTrade

Price performance (Past 24H)

Key statistics

iShares MSCI Canada (TSX) vs UnitedHealth Group Inc — how do they compare? iShares MSCI Canada (TSX) trades at $59.03 (market cap $6.99B), while UnitedHealth Group Inc trades at $379.3 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 47.6× iShares MSCI Canada (TSX)'s market cap, and UnitedHealth Group Inc pays a 2.5% dividend while iShares MSCI Canada (TSX) pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Canada (TSX) for 56 Days and UnitedHealth Group Inc for 97 Days on average.

EWCUNH
Market Cap
$6.99B$332.96B
Volume
1,625,8477,273,749
Sector
Broad Market / FactorHealth
52-Week High
$62.64$436.35
52-Week Low
$49.72$259.02
Typical Hold Time
56 Days97 Days
Enterprise Value
—$374.82B
Dividend Yield
—2.5%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI Canada (TSX)

EWC trades at $58.32, up 0.66% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. Key support is at $58, with resistance at $59. Financial ratios are unavailable, limiting fundamental clarity. Recent news highlights trade tensions with the U.S. and Canada's pursuit of EU associate membership, creating uncertainty.

The outlook is clouded by geopolitical risks and lack of financial data. Upside depends on resolving trade disputes, but downside risks from U.S. tariff threats and economic softening in Canada persist. Investors need updated earnings and valuation metrics to assess true potential amid volatile conditions.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.

UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EWC
100% Buy0% Sell
Avg holding period · 56 Days
UNH
71% Buy29% Sell
Avg holding period · 97 Days

Top news

Latest headlines on both assets

About iShares MSCI Canada (TSX)

EWC is a country-specific ETF that tracks the performance of the Canadian equity market. It provides exposure to large and mid-sized companies in Canada, with heavy concentrations in financials and energy, including Royal Bank of Canada, Shopify, and Enbridge.

Read more on EWC →

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH →